A family rather than one substance
PFOA and PFOS are familiar examples, but PFAS does not name a single chemical. Persistence, mobility, toxicity and behaviour during processing can differ. Start by identifying products, available composition information and uses. A marketing description such as water-resistant does not itself prove PFAS content, while a generic PFAS reference does not identify which compound the laboratory should analyse. Product-level information is therefore important before selecting tests.
Where occupational exposure may occur
NIOSH highlights chemical manufacture, certain firefighting activities and ski waxing among studied settings. Exposure depends on the product and actual work, including handling concentrates, aerosols and contaminated materials or waste. Consider skin exposure and inhalation according to the scenario. Membership of an occupational group alone does not establish a high dose for every worker; tasks and conditions must be investigated individually.
Separate the compound from the evidence
IARC classified PFOA as carcinogenic to humans and PFOS as possibly carcinogenic in its 2023 evaluation. These identify hazards of those compounds, not individual predictions or identical classifications for all PFAS. Other effects, including immune and metabolic effects, are also being investigated. Workplace conclusions need the specific substance, exposure information and relevant technical evidence. A family-wide label should not replace that assessment or imply equal risk from every use.
What to request during assessment
Gather supplier information, tasks, old and current products, waste routes and existing controls. The laboratory should specify which PFAS are measured, in which sample matrix and with what reporting limits. A panel result does not represent measurement of the whole family. Biological detection does not automatically identify an occupational source because other exposure sources may exist. Interpretation belongs to professionals who understand these limitations and the purpose of the investigation.
Make decisions with a defined scope
Assess elimination or substitution where feasible and reduce contact or emissions using appropriate controls. Substitution should evaluate the replacement hazard rather than merely changing a trade name. Legal restrictions vary by substance, use and date and require separate verification. There is no single number that can be applied indiscriminately as a safe limit for every PFAS in every workplace. Keep the assessment tied to identified compounds and actual conditions.
A product comparison must preserve the scope of the information received: an identified compound, a declared family and absence established through a defined analysis are different claims. A supplier statement saying PFOA-free does not establish absence of every PFAS. The decision should accurately reflect what is documented and what still needs clarification.
